Berkeley Lights focuses on speeding up the discovery and development of cell-based products and therapies in the biotechnology sector. The company provides a platform that integrates advanced technology for cell analysis, which includes proprietary consumables and automation systems. Their main product, the Berkeley Lights Platform, uses optofluidics—a technology that combines light and fluidics—to manipulate and analyze thousands of cells at once, allowing for detailed profiling of cell characteristics. This process helps clients, such as pharmaceutical companies and research institutions, to conduct their research more efficiently and achieve faster results in areas like antibody discovery and cell therapy development. Berkeley Lights stands out from competitors by offering a comprehensive system that combines hardware, consumables, and software, along with ongoing support. The company's goal is to enable quicker breakthroughs in disease treatment and biological research.